Overview A Safety and Tolerability Study OF PUR118 In Subjects With Cystic Fibrosis Status: Completed Trial end date: 2012-12-01 Target enrollment: Participant gender: Summary The purpose of this study is to determine whether PUR118 is safe and tolerable in a population of subjects with Cystic Fibrosis. Phase: Phase 1 Details Lead Sponsor: Pulmatrix Inc.Collaborator: Celerion